RNAC EPS Estimates - Cartesian Therapeutics, Inc. logo

RNAC EPS Estimates

Cartesian Therapeutics, Inc.

$6.14
+$0.25(+4.24%)
37
Overall
40
Value
40
Tech
31
Quality
How is this score calculated?
Market Cap
$187.29M
Volume
278.09K
52W Range
$5.60 - $11.00
Target Price
$33.67

RNAC EPS estimates: the consensus estimate for Cartesian Therapeutics, Inc.'s current fiscal year is -$2.19 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

RNAC EPS Estimates

EPS estimate, current quarter
$-0.85
EPS estimate, next quarter
$-0.75
EPS estimate, current year
$-2.19
EPS estimate, next year
$-3.25
EPS growth, 3-year
-100.00%
RNAC reported EPS by year
Fiscal yearEPS
2025$-5.02
2024$-4.48
2023$-49.80
2022$7.20
2021$-6.60
ABCD
1SymbolPriceChangeVol
2RNAC$6.14+4.2%278.09K
3
4
5
6

Get Cartesian Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.